Glucagon response study in new type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at how the body makes glucagon (a hormone that raises blood sugar) in children and teens with new type 1 diabetes. It aims to understand why some people may have dangerous low blood sugars, so doctors can better prevent them in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newly diagnosed type 1 diabetes (confirmed by standard tests and doctor evaluation)
- Age 2 to 18 years (some parts include up to age 30)
- Weigh at least 17 kg (about 37 pounds)
- Have at least one diabetes-related autoantibody in your blood
- Not taking certain medicines that affect insulin (like steroids or some diabetes pills)
- No other serious health conditions (like certain autoimmune diseases, epilepsy, or organ problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether very low-carbohydrate diets change glucagon response in adults with type 1 diabetes. It may help researchers understand how diet affects blood-sugar control in people using insulin pumps and continuous glucose monitors.
This study tests a new treatment called E-islet 01, which may help people with type 1 diabetes who have very low natural insulin production and have had dangerous low blood sugar events. The goal is to see if it is safe and can reduce those episodes.
This trial tests how two diabetes medications, SGLT2i and pioglitazone, affect ketone production in people with type 1 diabetes. It aims to find new ways to improve blood sugar control.
This study looks at how your body responds to low blood sugar during a controlled period of fasting. It may help doctors understand the natural defenses your body uses to prevent dangerous lows in type 1 diabetes.
This early study tests a new kind of donor islet transplant (UP421) designed to avoid rejection. It's for adults with long-standing type 1 diabetes who have trouble controlling blood sugar despite intensive insulin therapy.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
Hear when a new Severe Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.